Dean Carrington
Internal Medicine · Arlington, TXNPI 1861462491
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations.
Across 130 payments — averaging $14.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$271
- AstraZeneca$197
- Amarin Pharma, Inc.$192
- Novo Nordisk$171
- AbbVie$149
- Takeda Pharmaceuticals U.S.A., Inc.$106
- plus $748 from 19 others
What the payments were for
- Food & beverage$1,82199%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 19 | $271 |
| AstraZeneca | 12 | $197 |
| Amarin Pharma, Inc. | 16 | $192 |
| Novo Nordisk | 16 | $171 |
| AbbVie(2 entities) | 9 | $149 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $106 |
| Pfizer | 6 | $89 |
| Astellas Pharma US Inc | 5 | $78 |
| Sanofi-aventis U.S. LLC | 4 | $78 |
| Optinose US, Inc. | 4 | $63 |
| Lilly USA, LLC | 4 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Silk Road Medical, Inc. | 1 | $46 |
| Eisai Inc. | 3 | $38 |
| Kowa Pharmaceuticals America, Inc. | 3 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Johnson & Johnson | 2 | $32 |
| Sanofi Pasteur Inc. | 2 | $31 |
| Avanir Pharmaceuticals, Inc. | 2 | $28 |
| Grifols USA, LLC | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $17 |
| Boehringer Ingelheim | 1 | $12 |
| Merck | 1 | $12 |
How this compares
$1,833 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Arlington
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
- Hans LeeHouston$327K
- Tapan KadiaHouston$311K
- Nitin JainHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.